Garrett M. Frampton

Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response

Analysis of 260K tumors IDs copy-number signatures and a HRD biomarker predictive of PARPi response.